Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Pharmaceutical companies are currently navigating a challenging landscape marked by increasing pricing pressures, particularly from U.S. Medicare negotiations. As the…
Read more →